Meeting
2018 ASCO Annual Meeting
Genetic testing and results in population-based breast cancer patients and ovarian cancer patients.
Authors
Allison W. Kurian
Stanford School of Medicine, Stanford, CA
Allison W. Kurian , Kevin C. Ward , Nadia Howlader , Dennis Deapen , Ann S. Hamilton , Angela Mariotto , Daniel Miller , Steven J. Katz , Lynne Penberthy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 36, 2018 (suppl; abstr 1578)
DOI
10.1200/JCO.2018.36.15_suppl.1578
Abstract #
1578
Poster Bd #
149
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Women with pathogenic variants in moderate penetrance breast cancer genes: How frequently do they meet high penetrance genetic testing criteria?
First Author: Nicole Casasanta
Poster
2018 ASCO Annual Meeting
Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group.
First Author: Sarah Nielsen
Poster
2022 ASCO Annual Meeting
Germline mutations in ATM, CHEK2, and other known/potential breast cancer susceptibility genes among BRCA-negative Uruguayan patients with breast cancer.
First Author: Lucia Beatriz Delgado
Poster
2022 ASCO Annual Meeting
Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD).
First Author: Lorena Incorvaia